Press Releases News Year None20192018201720162015201420132012 IVERIC bio, Inc. Announces Pricing of Public Offering of Common Stock Dec 06, 2019 | IVERIC bio, Inc. Announces Proposed Offering of Common Stock Dec 05, 2019 | IVERIC bio to Present at Evercore ISI 2nd Annual HealthCONx Conference Nov 26, 2019 | IVERIC bio Appoints Guangping Gao, PhD, Internationally Recognized Gene Therapy Pioneer as Chief Strategist, Gene Therapy Nov 25, 2019 | IVERIC bio to Host a Zimura® R&D Symposium for Investors / Analysts on November 20, 2019 Nov 14, 2019 | IVERIC bio Reports Third Quarter 2019 Operational Highlights and Financial Results Nov 12, 2019 | IVERIC bio Initiating Second Pivotal Clinical Trial of Zimura® in GA with 1Q 2020 Targeted for First Patient Enrolled Nov 12, 2019 | IVERIC bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Nov 05, 2019 | IVERIC bio to Report Third Quarter 2019 Financial Results and Host Conference Call on Tuesday, November 12, 2019 Nov 04, 2019 | IVERIC bio Appoints Abraham Scaria, PhD, as Chief Scientific Officer Oct 29, 2019 | Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
IVERIC bio Appoints Guangping Gao, PhD, Internationally Recognized Gene Therapy Pioneer as Chief Strategist, Gene Therapy Nov 25, 2019 |
IVERIC bio to Host a Zimura® R&D Symposium for Investors / Analysts on November 20, 2019 Nov 14, 2019 |
IVERIC bio Initiating Second Pivotal Clinical Trial of Zimura® in GA with 1Q 2020 Targeted for First Patient Enrolled Nov 12, 2019 |
IVERIC bio to Report Third Quarter 2019 Financial Results and Host Conference Call on Tuesday, November 12, 2019 Nov 04, 2019 |
Press Releases News Year None20192018201720162015201420132012 IVERIC bio, Inc. Announces Pricing of Public Offering of Common Stock Dec 06, 2019 | IVERIC bio, Inc. Announces Proposed Offering of Common Stock Dec 05, 2019 | IVERIC bio to Present at Evercore ISI 2nd Annual HealthCONx Conference Nov 26, 2019 | IVERIC bio Appoints Guangping Gao, PhD, Internationally Recognized Gene Therapy Pioneer as Chief Strategist, Gene Therapy Nov 25, 2019 | IVERIC bio to Host a Zimura® R&D Symposium for Investors / Analysts on November 20, 2019 Nov 14, 2019 | IVERIC bio Reports Third Quarter 2019 Operational Highlights and Financial Results Nov 12, 2019 | IVERIC bio Initiating Second Pivotal Clinical Trial of Zimura® in GA with 1Q 2020 Targeted for First Patient Enrolled Nov 12, 2019 | IVERIC bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Nov 05, 2019 | IVERIC bio to Report Third Quarter 2019 Financial Results and Host Conference Call on Tuesday, November 12, 2019 Nov 04, 2019 | IVERIC bio Appoints Abraham Scaria, PhD, as Chief Scientific Officer Oct 29, 2019 | Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
IVERIC bio Appoints Guangping Gao, PhD, Internationally Recognized Gene Therapy Pioneer as Chief Strategist, Gene Therapy Nov 25, 2019 |
IVERIC bio to Host a Zimura® R&D Symposium for Investors / Analysts on November 20, 2019 Nov 14, 2019 |
IVERIC bio Initiating Second Pivotal Clinical Trial of Zimura® in GA with 1Q 2020 Targeted for First Patient Enrolled Nov 12, 2019 |
IVERIC bio to Report Third Quarter 2019 Financial Results and Host Conference Call on Tuesday, November 12, 2019 Nov 04, 2019 |
